Avery Everhart

Ms. Avery Everhart

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 September 2021 in Journal of the American Medical Informatics Association
Verified
Journal Article
Open access
PDF file
CKClair A Kronk
Clair A Kronk
AEAvery Everhart
Avery Everhart
FAFlorence Ashley
Florence Ashley
HTHale M Thompson
Hale M Thompson
TSTheodore E Schall
Theodore E Schall
RKRyan Karnoski
Ryan Karnoski
There are over 1 million transgender people living in the United States, and 33% report negative experiences with a healthcare provider, many of which are connected to data representation in electronic health records (EHRs). We present recommendations and common pitfalls involving sex- and gender-related data collection in EHRs. Our recommendations leverage the needs of patients, medical providers, and researchers to optimize both individual patient experiences and the efficacy and reproducibility of EHR population-based studies. We also briefly discuss adequate additions to the EHR considering name and pronoun usage. We add the disclaimer that these questions are more complex than commonly assumed. We conclude that collaborations between local transgender and gender-diverse persons and medical providers as well as open inclusion of transgender and gender-diverse individuals on terminology and standards boards is crucial to shifting the paradigm in transgender and gender-diverse health.

1 January 2022 in Annals of Epidemiology
Verified
Journal Article
Closed access
LLLanair Lett
Lanair Lett
AEAvery Everhart
Avery Everhart

8 February 2022 in Social Psychiatry and Psychiatric Epidemiology
Verified
Journal Article
Closed access
PDF file
LLLanair Lett
Lanair Lett
Matthew P AbramsMatthew P Abrams
Matthew P Abrams
AGArya Gold
Arya Gold
FFFarrah-Amoy Fullerton
Farrah-Amoy Fullerton
AEAvery Everhart
Avery Everhart

1 January 2022 in Social Science & Medicine
Verified
Journal Article
Open access
AEAvery Everhart
Avery Everhart
HBHayden Boska
Hayden Boska
HSHagit Sinai-Glazer
Hagit Sinai-Glazer
JWJia Qing Wilson-Yang
Jia Qing Wilson-Yang
NBNora Butler Burke
Nora Butler Burke
ZMZack Marshall
Zack Marshall
This paper presents results of a research priority setting process focused on trans women living with and affected by HIV across Canada. It features data from semi-structured interviews and focus groups conducted with a diverse group of 76 trans women in five urban centers across the country on how they have navigated health and social service programming within their geographic context. The results focus on the structure and types of services. Respondents offered simple, yet creative ways to address barriers to vital services based on their individual and collective experiences. Notably, participants stressed the need for 1) trans-friendly and trans-specific services, 2) integrated health services, and aid in navigating complex, overlapping systems, and 3) comprehensive community-based services. They also suggest employing trans women as care coordinators or case managers in order to foster more trans-friendly environments and empower community members. We identify concrete ways to improve health and social services at the level of service delivery and program design, as well as recommendations for future participatory research. We close with an interrogation of trans people, and trans women living with and affected by HIV in particular, as 'hard to reach' populations.

7 September 2022 in Humanities and Social Sciences Communications
Verified
Journal Article
Open access
PDF file
ARArjee Restar
Arjee Restar
EDE. J. Dusic
E. J. Dusic
HGHenri Garrison-Desany
Henri Garrison-Desany
ELElle Lett
Elle Lett
AEAvery Everhart
Avery Everhart
JHJaclyn M. W. Hughto
Jaclyn M. W. Hughto
Gender-affirming hormones have been shown to improve psychological functioning and quality of life among transgender and nonbinary (trans) people, yet, scant research exists regarding whether and why individuals take more or less hormones than prescribed. Drawing on survey data from 379 trans people who were prescribed hormones, we utilized multivariable logistic regression models to identify factors associated with hormone-dosing behaviors and content analysis to examine the reasons for dose modifications. Overall, 24% of trans individuals took more hormones than prescribed and 57% took less. Taking more hormones than prescribed was significantly associated with having the same provider for primary and gender-affirming care and gender-based discrimination. Income and insurance coverage barriers were significantly associated with taking less hormones than prescribed. Differences by gender identity were also observed. Addressing barriers to hormone access and cost could help to ensure safe hormone-dosing behaviors and the achievement trans people’s gender-affirmation goals.

3 May 2025 in Social Science & Medicine
Verified
Journal Article
Open access
ASAyden I. Scheim
Ayden I. Scheim
ARArjee J. Restar
Arjee J. Restar
DZDougie Zubizarreta
Dougie Zubizarreta
RLRuby Lucas
Ruby Lucas
SBSam Wilson Beckham
Sam Wilson Beckham
MRMaria I. Rodriguez
Maria I. Rodriguez
Legal gender recognition (LGR) refers to laws, policies, and administrative procedures that enable transgender and gender diverse (TGD) people to update their legal identity documents (ID) to reflect their self-determined gender. We conducted a systematic review and meta-analysis on the health effects of LGR and a nested scoping review of TGD people's LGR-related values and preferences (PROSPERO CRD42023441769). We searched seven databases through April 19, 2024, and organization websites (for grey literature) through August 2023. The effectiveness review included quantitative studies evaluating the effect of LGR (policies or possession of gender-concordant ID) on seven domains of health and well-being. We conducted random-effects meta-analyses when possible and otherwise used narrative synthesis. Study risk of bias and confidence in the cumulative evidence were assessed using the ROBINS-E and GRADE, respectively. We screened 2748 studies and included 24 in the effectiveness review. In meta-analyses, LGR was associated with less suicidal ideation (OR = 0.75; 95 % CI: 0.56-1.00, I2 = 46 %) and psychological distress (e.g., OR for LGR on all versus no ID = 0.53; 95 % CI: 0.40, 0.70, I2 = 17 %). LGR may reduce anticipated discrimination, increase healthcare utilization, reduce gonadectomies, and improve socio-economic status, but the evidence was very uncertain. We included 31 studies on TGD persons' values and preferences. They perceived well-being benefits of LGR, had diverse personal preferences related to safety, and reported financial and policy barriers to LGR. In conclusion, LGR may improve TGD mental health and is perceived to reduce exposure to stigma and discrimination. Higher-quality effectiveness research is needed on other health and well-being outcomes, as well as research to evaluate specific LGR policy provisions.